New test may help DCIS patients avoid unnecessary treatments
NCT ID NCT04916808
First seen Apr 10, 2026 · Last updated May 19, 2026 · Updated 5 times
Summary
This study follows 1,500 people with ductal carcinoma in situ (DCIS), a very early form of breast cancer, to see if a test called DCISionRT changes what treatments doctors recommend. Participants have already had breast-conserving surgery. The goal is to learn whether the test helps tailor treatments like radiation or hormone therapy to each person's risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DCIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GenesisCare
Alexandria, New South Wales, 2015, Australia
-
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
Conditions
Explore the condition pages connected to this study.